Toronto Dominion Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Toronto Dominion Bank's MRNA Position: Q2 2026 in Review
Toronto Dominion Bank increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $461K and bringing the position to 70,922 shares worth $4.97M. The position accounts for 0.01% of the portfolio, ranked #937.
Toronto Dominion Bank first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $120M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Toronto Dominion Bank held 70,922 shares of Moderna worth $4.97M as of Q2 2026.
- Toronto Dominion Bank bought 8,910 Moderna shares in Q2 2026, an estimated $461K.
- Moderna made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #937 holding.
- Toronto Dominion Bank first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
- Toronto Dominion Bank's Moderna position peaked at $120M in Q3 2021.
- 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.